CAMG
AUPH icon

CWA Asset Management Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

CWA Asset Management Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44M Buy
202,440
+16,107
+9% +$257K 0.1% 200
2026
Q1 		$2.76M Buy
186,333
+57,132
+44% +$835K 0.09% 211
2025
Q4 		$2.06M Buy
129,201
+5,649
+5% +$80.1K 0.07% 223
2025
Q3 		$1.37M Buy
123,552
+16,154
+15% +$176K 0.05% 303
2025
Q2 		$910K Buy
107,398
+22,131
+26% +$177K 0.04% 344
2025
Q1 		$686K Buy
85,267
+40,878
+92% +$331K 0.03% 369
2024
Q4 		$399K Buy
+44,389
New +$362K 0.02% 427

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CWA Asset Management Group's AUPH Position: Q2 2026 in Review

CWA Asset Management Group increased its Aurinia Pharmaceuticals (AUPH) stake by 8.6% in Q2 2026, buying an estimated $257K and bringing the position to 202,440 shares worth $3.44M. The position accounts for 0.1% of the portfolio, ranked #200.

CWA Asset Management Group first reported a position in AUPH in Q4 2024 and has held it in 7 quarters since. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • CWA Asset Management Group held 202,440 shares of Aurinia Pharmaceuticals worth $3.44M as of Q2 2026.
  • CWA Asset Management Group bought 16,107 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $257K.
  • Aurinia Pharmaceuticals made up 0.1% of CWA Asset Management Group's portfolio in Q2 2026, its #200 holding.
  • CWA Asset Management Group first reported a position in Aurinia Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.